Skip to main content

Detailsite

International cancer research consortium with Austrian involvement

(Vienna, 16 June 2010) With Priv. Doz. Dr. Boban Erovic a specialist from the ENT Clinic at MedUni Vienna has now been invited to take part in the internationally active "Middle Eastern Cancer Society" (MECC) for the first time. This consortium was founded by Professor Kishor Bhatia, Director of the NCI/NIH (National Cancer Institute/National Institute of Health) since 2005, with the aim of creating an international and interinstitutional network of data and research themes in the field of Merkel cell carcinomas. This skin tumour is very rare but extremely malignant and is associated with a very high mortality rate. Professor Bathia is also a member of the "Rockville Merkel Cell Carcinoma Group".

Boban Erovic has been working at the ENT Clinic since December 2001 and qualified as a professor in June 2006 with the subject “Prognostic/predictive factors in malignant head and neck tumours". As part of his clinical work, Erovic has started to become particularly interested in the extremely malignant Merkel cell carcinomas, and since 2007 - in cooperation with colleagues from pathology (Prof. Pammer), dermatology (Prof. Petzelbauer) and with the Department of Dermatology, Würzburg (Prof. Becker, Dr. Houben) - has started to carry out studies on Merkel cell carcinomas. Since 2008 these cooperation projects have also led to several publications in relevant journals in the fields of ENT and also pathology, and collaboration with the Universities of Toronto, New York and Sydney has also begun. Now the next meeting of the Middle Eastern Cancer Society and Rockville Merkel Cell Carcinoma Group (22 June 2010 in Bethesda, Maryland, at the National Institute of Health) is also going to take place with Boban Erovic involved.

Currently Priv. Doz. Dr. Boban Erovic is working at the Department of ENT, Head and Neck Surgery, University of Toronto. Here since July 2009 he has been completing a two-year scientific and clinical training programme in oncological head and neck surgery.
He is currently working on the following research projects:

• “Evaluation of predictive factors in tissue specimens of patients with head and neck cancer” (Investigator, since 2005)
• “Evaluation of Quality of Life by the UWQOL and SCL-90-R questionnaires after tranversal or longitudinal partial glossectomy in patients with T1N0 tongue carcinoma” (Investigator, since 2008)
• “Management of malignant primary tumors of the salivary and sebaceous glands” (Investigator, since 2008)
• “Development of new 3D-navigation and drill tracking systems for temporal bone and skull base surgery” (Investigator, since 2008)
• “Definition of new diagnostic, prognostic and predictive factors in endocrine tumors of the head and neck” (Investigator, since 2008)


Links:
» Middle East Cancer Consortium (MECC)
» The Rockville Merkel Cell Carcinoma Group